HUMAN ANTICHIMERIC ANTIBODY POSITIVE

This adverse event was reported 305 times

These drugs are most commonly taken by patients reporting HUMAN ANTICHIMERIC ANTIBODY POSITIVE:

# Drug Count
0 ETANERCEPT 283
1 INFLIXIMAB 283
2 METHOTREXATE SODIUM 283
3 TOCILIZUMAB 283
4 ABATACEPT 282
5 ADALIMUMAB 282
6 SULFASALAZINE 281
7 ANAKINRA 279
8 METHOTREXATE 267
9 PREDNISONE 267
See all common drugs associated with HUMAN ANTICHIMERIC ANTIBODY POSITIVE

HUMAN ANTICHIMERIC ANTIBODY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRIAMCINOLONE HEXACETONIDE 125 0.5319
1 VACCINIA IMMUNE GLOBULIN (HUMAN) 2 0.0303
2 ANAKINRA 279 0.0209
3 TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% 118 0.0087
4 ADALIMUMAB-AATY 165 0.0070
5 ADALIMUMAB-ADAZ 165 0.0062
6 TRIAMCINOLONE ACETONIDE 118 0.0057
7 SULFASALAZINE 281 0.0043
8 HUMAN IMMUNOGLOBULIN G 38 0.0037
9 TOCILIZUMAB 283 0.0031
See all drugs enriched for association with HUMAN ANTICHIMERIC ANTIBODY POSITIVE

HUMAN ANTICHIMERIC ANTIBODY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-1 Receptor Antagonist [EPC] 279 0.0209
1 Human Immunoglobulin G [EPC] 39 0.0037
2 Interleukin-6 Receptor Antagonist [EPC] 283 0.0028
3 Aminosalicylate [EPC] 282 0.0026
4 Selective T Cell Costimulation Modulator [EPC] 282 0.0025
5 Folate Analog Metabolic Inhibitor [EPC] 267 0.0007
6 Tumor Necrosis Factor Blocker [EPC] 297 0.0003
7 Corticosteroid [EPC] 277 0.0003
8 Vitamin D [EPC] 57 0.0002
9 Vitamin B12 [EPC] 57 0.0002
See all drug classes enriched for association with HUMAN ANTICHIMERIC ANTIBODY POSITIVE